These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 17116360)

  • 1. Human papilloma virus DNA and p53 mutation analysis on bladder washes in relation to clinical outcome of bladder cancer.
    Moonen PM; Bakkers JM; Kiemeney LA; Schalken JA; Melchers WJ; Witjes JA
    Eur Urol; 2007 Aug; 52(2):464-8. PubMed ID: 17116360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re: Paula M.J. Moonen, Judith M.J.E. Bakkers, Lambertus A.L.M. Kiemenay et al. Human papilloma virus DNA and p53 mutation analysis on bladder washes in relation to clinical outcome of bladder cancer. Eur Urol 2007;52:464-9.
    Cai T; Mazzoli S; Mondaini N; Bartoletti R
    Eur Urol; 2008 Apr; 53(4):858-9; author reply 859. PubMed ID: 17920185
    [No Abstract]   [Full Text] [Related]  

  • 3. p53 overexpression and human papillomavirus infection in transitional cell carcinoma of the urinary bladder: correlation with histological parameters.
    Tenti P; Zappatore R; Romagnoli S; Civardi E; Giunta P; Scelsi R; Stella G; Carnevali L
    J Pathol; 1996 Jan; 178(1):65-70. PubMed ID: 8778319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumorgenesis due to papillomavirus infection was first demonstrated in rabbits and cattle early last century.
    Schmitz-Drager BJ
    Eur Urol; 2007 Aug; 52(2):468-9. PubMed ID: 17674437
    [No Abstract]   [Full Text] [Related]  

  • 5. The study on relation of human papillomavirus and P53 expression with bladder transitional cell carcinoma.
    Chen T; Kong Q; Cao H
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Dec; 14(4):345-8. PubMed ID: 11471022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival.
    Haraf DJ; Nodzenski E; Brachman D; Mick R; Montag A; Graves D; Vokes EE; Weichselbaum RR
    Clin Cancer Res; 1996 Apr; 2(4):755-62. PubMed ID: 9816227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papilloma virus (HPV) and p53 immunostaining in advanced tonsillar carcinoma--relation to radiotherapy response and survival.
    Friesland S; Mellin H; Munck-Wikland E; Nilsson A; Lindholm J; Dalianis T; Lewensohn R
    Anticancer Res; 2001; 21(1B):529-34. PubMed ID: 11299799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic alterations of the TP53 gene, p53 protein expression and HPV infection in primary cervical carcinomas.
    Helland A; Holm R; Kristensen G; Kaern J; Karlsen F; Trope C; Nesland JM; Børresen AL
    J Pathol; 1993 Oct; 171(2):105-14. PubMed ID: 8283348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-risk human papillomavirus infections and overexpression of p53 protein as prognostic indicators in transitional cell carcinoma of the urinary bladder.
    Furihata M; Inoue K; Ohtsuki Y; Hashimoto H; Terao N; Fujita Y
    Cancer Res; 1993 Oct; 53(20):4823-7. PubMed ID: 8402668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer.
    Brachman DG; Graves D; Vokes E; Beckett M; Haraf D; Montag A; Dunphy E; Mick R; Yandell D; Weichselbaum RR
    Cancer Res; 1992 Sep; 52(17):4832-6. PubMed ID: 1324797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of human papilloma virus DNA in head and neck cancers carrying wild-type or mutant p53 tumor suppressor genes.
    Adams V; Schmid S; Zariwala M; Schmid M; Kleihues P; Briner J; Schäfer R
    Anticancer Res; 1999; 19(1A):1-6. PubMed ID: 10226517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus and p53 mutational status as prognostic factors in head and neck carcinoma.
    Sisk EA; Soltys SG; Zhu S; Fisher SG; Carey TE; Bradford CR
    Head Neck; 2002 Sep; 24(9):841-9. PubMed ID: 12211048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus infection and p53 nuclear overexpression in anal canal carcinoma.
    Indinnimeo M; Cicchini C; Stazi A; Giarnieri E; French D; Limiti MR; Ghini C; Vecchione A
    J Exp Clin Cancer Res; 1999 Mar; 18(1):47-52. PubMed ID: 10374676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of HPV type 16, 18 infection and p53 protein overexpression in oral squamous cell carcinoma].
    Minawaer ; Ahmatjan A; Suzuk L
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2001 Nov; 36(6):451-3. PubMed ID: 11930724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-risk human papillomavirus (HPV) is not associated with p53 and bcl-2 expression in oral squamous cell carcinomas.
    Oliveira MC; Soares RC; Pinto LP; Souza LB; Medeiros SR; Costa Ade L
    Auris Nasus Larynx; 2009 Aug; 36(4):450-6. PubMed ID: 19124208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications of p53 mutation analysis in bladder cancer tissue and urine sediment by functional assay in yeast.
    Schlichtholz B; Presler M; Matuszewski M
    Carcinogenesis; 2004 Dec; 25(12):2319-23. PubMed ID: 15308588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of human papillomavirus DNA, serum p53, and p53 antibodies in patients with cervical cancer.
    Sobti RC; Parashar K; Kaur R; Capalash N
    J Environ Pathol Toxicol Oncol; 2002; 21(1):79-85. PubMed ID: 11934017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women.
    Cheng YW; Chiou HL; Sheu GT; Hsieh LL; Chen JT; Chen CY; Su JM; Lee H
    Cancer Res; 2001 Apr; 61(7):2799-803. PubMed ID: 11306446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of human papillomavirus in transitional cell carcinomas of the urinary bladder in South Africa.
    Sur M; Cooper K; Allard U
    Pathology; 2001 Feb; 33(1):17-20. PubMed ID: 11280602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].
    Ergünay K; Misirlioğlu M; Firat P; Tuncer ZS; Tuncer S; Yildiz I; Ustaçelebi S
    Mikrobiyol Bul; 2008 Apr; 42(2):273-82. PubMed ID: 18697425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.